USA flag logo/image

An Official Website of the United States Government

A STAINING METHOD FOR ELECTROPHORETICALLY SEPARATED CLOTTINGFACTORS

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
13936
Program Year/Program:
1990 / SBIR
Agency Tracking Number:
13936
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ELCATECH, INC.
101 N CHESTNUT STREET Winston-salem, NC 27101
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1990
Title: A STAINING METHOD FOR ELECTROPHORETICALLY SEPARATED CLOTTINGFACTORS
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THIS PROJECT WILL DEVELOP AN ELECTROPHORETIC STAINING METHOD FOR CLOTTING FACTORS. THE METHOD MEASURES COAGULATION USING A COLORIMETRIC SYSTEM KNOWN AS ENZYME-LINKED COAGULATION ASSAY (ELCA). ELCA IS BASED ON THE SIMULTANEOUS CONVERSION OF SOLID-PHASE-ASSOCIATED FIBRINOGEN AND ENZYME-LABELED FIBRINOGEN IN SOLUTION BY THROMBIN, WHICH IS GENERATED IN OR ADDED TO THE SOLID-PHASE-ASSOCIATED MIXTURE. IN THIS STUDY, NITROCELLULOSE MEMBRANES WILL EITHER BIND THE CLOTTING FACTOR BY BLOTTING TRANSFER OR BE USED AS A SUBSTRATE VEHICLE FOR IDENTIFICATION OF THE LOCATION OF BANDS FROM ELECTROPHEROGRAMS; THE MEMBRANES WILL BE FIBRINOGEN COATED AND BLOCKED WITH CASEIN. ELCA ASSAYS WILLBE PERFORMED BY ADDING SUBSTRATE CONTAINING ALL FACTORS NEEDED FOR ASSAY OF A PARTICULAR FACTOR INCLUDING LABELED FIBRINOGEN. TWO PROTOCOLS FOR IDENTIFICATION OF THE SEPARATED COMPONENTSWILL BE USED. IN THE FIRST, THE SOLID PHASE WILL HAVE BOUND TO IT CLOTTING FACTORS TRANSFERRED FROM NONDENATURING ELECTROPHEROGRAMS; IN THE SECOND, THE SOLID PHASE WILL BE OVERLAID DIRECTLY ONTO POLYACRYLAMIDE GELS WITH SEPARATED CLOTTING FACTORS. THIS WILL PERMIT THE FUNCTIONAL IDENTIFICATION OF ACTIVE CLOTTING FACTORS ON ELECTROPHEROGRAMS. THIS WILL BE OF USE IN THE IDENTIFICATION OF GENETIC VARIANTS, ACTIVE AND ACTIVATED CLOTTING FACTORS IN PLASMA SAMPLES, AND PARTIALLY CARBOXYLATED CLOTTING FACTORS FROM COUMADIN-TREATED PATIENTS.

Principal Investigator:

George J Doellgast
9197773624

Business Contact:

Small Business Information at Submission:

Elcatech Inc
4291 Lantern Dr Winston-salem, NC 27106

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No